메뉴 건너뛰기




Volumn 43, Issue 1, 2016, Pages 21-33

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride

Author keywords

223Ra dichloride; Bone metastases; Dosimetry; Radionuclide therapy

Indexed keywords

LEXIDRONAM SAMARIUM SM 153; RADIUM CHLORIDE RA 223; TECHNETIUM 99M; RADIOISOTOPE; RADIUM; TECHNETIUM COMPLEX;

EID: 84951905607     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-015-3150-2     Document Type: Article
Times cited : (110)

References (42)
  • 1
    • 33750726077 scopus 로고    scopus 로고
    • Clinical features of metastatic bone disease and risk of skeletal morbidity
    • PID: 17062708
    • Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s–9s.
    • (2006) Clin Cancer Res , vol.12 , pp. 6243-6249
    • Coleman, R.E.1
  • 2
    • 75749110617 scopus 로고    scopus 로고
    • MIRD pamphlet no. 22 (abridged): radiobiology and dosimetry of α-particle emitters for targeted radionuclide therapy
    • COI: 1:CAS:528:DC%2BC3cXivFWmsbo%3D, PID: 20080889
    • Sgouros G, Roeske JC, McDevitt MR, Palm S, Allen BJ, Fisher DR, et al. MIRD pamphlet no. 22 (abridged): radiobiology and dosimetry of α-particle emitters for targeted radionuclide therapy. J Nucl Med. 2010;51:311–28.
    • (2010) J Nucl Med , vol.51 , pp. 311-328
    • Sgouros, G.1    Roeske, J.C.2    McDevitt, M.R.3    Palm, S.4    Allen, B.J.5    Fisher, D.R.6
  • 3
    • 84860677986 scopus 로고    scopus 로고
    • A bone marrow toxicity model for Ra-223 α-emitter radiopharmaceutical therapy
    • COI: 1:CAS:528:DC%2BC38XhtVGgs7%2FN, PID: 22546715
    • Hobbs RF, Song H, Watchman CJ, Bolch WE, Aksnes AK, Ramdahl T, et al. A bone marrow toxicity model for Ra-223 α-emitter radiopharmaceutical therapy. Phys Med Biol. 2012;57:3207–22.
    • (2012) Phys Med Biol , vol.57 , pp. 3207-3222
    • Hobbs, R.F.1    Song, H.2    Watchman, C.J.3    Bolch, W.E.4    Aksnes, A.K.5    Ramdahl, T.6
  • 4
    • 84951906335 scopus 로고    scopus 로고
    • Cancer Therapy Evaluation Program: National Cancer Institute
    • CTEP. Common terminology criteria for adverse events (CTCAE) v4.0. Bethesda, MD: Cancer Therapy Evaluation Program, National Cancer Institute; 2015. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Accessed 1 Aug 2015.
    • (2015) MD
  • 5
    • 20644447798 scopus 로고    scopus 로고
    • First clinical experience with α-emitting radium-223 in the treatment of skeletal metastases
    • COI: 1:CAS:528:DC%2BD2MXltFeksrc%3D, PID: 15958630
    • Nilsson S, Larsen RH, Fossa SD, Balteskard L, Borch KW, Westlin JE, et al. First clinical experience with α-emitting radium-223 in the treatment of skeletal metastases. Clin Cancer Res. 2005;11:4451–9.
    • (2005) Clin Cancer Res , vol.11 , pp. 4451-4459
    • Nilsson, S.1    Larsen, R.H.2    Fossa, S.D.3    Balteskard, L.4    Borch, K.W.5    Westlin, J.E.6
  • 6
    • 34347244905 scopus 로고    scopus 로고
    • Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
    • COI: 1:CAS:528:DC%2BD2sXnsFKkurw%3D, PID: 17544845
    • Nilsson S, Franzen L, Parker C, Tyrrell C, Blom R, Tennvall J, et al. Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. Lancet Oncol. 2007;8:587–94.
    • (2007) Lancet Oncol , vol.8 , pp. 587-594
    • Nilsson, S.1    Franzen, L.2    Parker, C.3    Tyrrell, C.4    Blom, R.5    Tennvall, J.6
  • 7
    • 84871926771 scopus 로고    scopus 로고
    • A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer
    • COI: 1:CAS:528:DC%2BC38XhsVSltLvP, PID: 23000088
    • Parker CC, Pascoe S, Chodacki A, O'Sullivan JM, Germá JR, O'Bryan-Tear CG, et al. A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer. Eur Urol. 2013;63:189–97.
    • (2013) Eur Urol , vol.63 , pp. 189-197
    • Parker, C.C.1    Pascoe, S.2    Chodacki, A.3    O'Sullivan, J.M.4    Germá, J.R.5    O'Bryan-Tear, C.G.6
  • 8
    • 84897939554 scopus 로고    scopus 로고
    • Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-Dichloride
    • COI: 1:CAS:528:DC%2BC2cXltlaqtL8%3D, PID: 24343987
    • Pandit-Taskar N, Larson SM, Carrasquillo JA. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-Dichloride. J Nucl Med. 2014;55:268–74.
    • (2014) J Nucl Med , vol.55 , pp. 268-274
    • Pandit-Taskar, N.1    Larson, S.M.2    Carrasquillo, J.A.3
  • 9
    • 84858706749 scopus 로고    scopus 로고
    • A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
    • COI: 1:CAS:528:DC%2BC38Xkt1Gmt78%3D, PID: 22341993
    • Nilsson S, Strang P, Aksnes AK, Franzèn L, Olivier P, Pecking A, et al. A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. Eur J Cancer. 2012;48:678–86.
    • (2012) Eur J Cancer , vol.48 , pp. 678-686
    • Nilsson, S.1    Strang, P.2    Aksnes, A.K.3    Franzèn, L.4    Olivier, P.5    Pecking, A.6
  • 10
    • 33646894695 scopus 로고    scopus 로고
    • Radiotoxicity of the α-emitting bone-seeker Ra-223 injected intravenously into mice: histology, clinical chemistry and hematology
    • COI: 1:CAS:528:DC%2BD28XlvVWiu7Y%3D, PID: 16724665
    • Larsen RH, Saxtorph H, Skydsgaard M, Borrebaek J, Jonasdottir TJ, Bruland OS, et al. Radiotoxicity of the α-emitting bone-seeker Ra-223 injected intravenously into mice: histology, clinical chemistry and hematology. In Vivo. 2006;20:325–31.
    • (2006) In Vivo , vol.20 , pp. 325-331
    • Larsen, R.H.1    Saxtorph, H.2    Skydsgaard, M.3    Borrebaek, J.4    Jonasdottir, T.J.5    Bruland, O.S.6
  • 11
    • 84888303650 scopus 로고    scopus 로고
    • Targeted α-particle therapy of bone metastases in prostate cancer
    • PID: 24212441
    • Jadvar H, Quinn DI. Targeted α-particle therapy of bone metastases in prostate cancer. Clin Nucl Med. 2013;38:966–71.
    • (2013) Clin Nucl Med , vol.38 , pp. 966-971
    • Jadvar, H.1    Quinn, D.I.2
  • 12
    • 0036606104 scopus 로고    scopus 로고
    • Significant antitumor effect from bone-seeking, α-particle-emitting Ra-223 demonstrated in an experimental skeletal metastases model
    • COI: 1:CAS:528:DC%2BD38XksVyqsrY%3D, PID: 12036923
    • Henriksen G, Breistol K, Bruland OS, Fodstad O, Larsen RH. Significant antitumor effect from bone-seeking, α-particle-emitting Ra-223 demonstrated in an experimental skeletal metastases model. Cancer Res. 2002;62:3120–5.
    • (2002) Cancer Res , vol.62 , pp. 3120-3125
    • Henriksen, G.1    Breistol, K.2    Bruland, O.S.3    Fodstad, O.4    Larsen, R.H.5
  • 13
    • 84880428467 scopus 로고    scopus 로고
    • Alpha emitter radium-223 and survival in metastatic prostate cancer
    • COI: 1:CAS:528:DC%2BC3sXhtFKls77M, PID: 23863050
    • Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369:213–23.
    • (2013) N Engl J Med , vol.369 , pp. 213-223
    • Parker, C.1    Nilsson, S.2    Heinrich, D.3    Helle, S.I.4    O'Sullivan, J.M.5    Fosså, S.D.6
  • 14
    • 84874106208 scopus 로고    scopus 로고
    • Dosimetry of 223Ra-chloride: dose to normal organs and tissues
    • COI: 1:CAS:528:DC%2BC3sXkvVKmsA%3D%3D, PID: 23053328
    • Lassmann M, Nosske D. Dosimetry of 223Ra-chloride: dose to normal organs and tissues. Eur J Nucl Med Mol Imaging. 2013;40:207–12.
    • (2013) Eur J Nucl Med Mol Imaging , vol.40 , pp. 207-212
    • Lassmann, M.1    Nosske, D.2
  • 15
    • 84881630281 scopus 로고    scopus 로고
    • Phase I pharmacokinetic and biodistribution study with escalating doses of Ra-dichloride in men with castration-resistant metastatic prostate cancer
    • COI: 1:CAS:528:DC%2BC3sXht1Gmu7fF, PID: 23653243
    • Carrasquillo JA, O’Donoghue JA, Pandit-Taskar N, Humm JL, Rathkopf DE, Slovin SF, et al. Phase I pharmacokinetic and biodistribution study with escalating doses of Ra-dichloride in men with castration-resistant metastatic prostate cancer. Eur J Nucl Med Mol Imaging. 2013;40:1384–93.
    • (2013) Eur J Nucl Med Mol Imaging , vol.40 , pp. 1384-1393
    • Carrasquillo, J.A.1    O’Donoghue, J.A.2    Pandit-Taskar, N.3    Humm, J.L.4    Rathkopf, D.E.5    Slovin, S.F.6
  • 16
    • 84862239106 scopus 로고    scopus 로고
    • Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases
    • COI: 1:CAS:528:DC%2BC38XhtFKnsbvI, PID: 22513884
    • Hindorf C, Chittenden S, Aksnes AK, Parker C, Flux GD. Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases. Nucl Med Commun. 2012;33:726–32.
    • (2012) Nucl Med Commun , vol.33 , pp. 726-732
    • Hindorf, C.1    Chittenden, S.2    Aksnes, A.K.3    Parker, C.4    Flux, G.D.5
  • 18
    • 16744365716 scopus 로고    scopus 로고
    • MIRD Pamphlet No. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates
    • COI: 1:CAS:528:DyaK1MXivVGlsrg%3D, PID: 10025848
    • Siegel JA, Thomas SR, Stubbs JB. MIRD Pamphlet No. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40:37s–61s.
    • (1999) J Nucl Med , vol.40 , pp. 37-61
    • Siegel, J.A.1    Thomas, S.R.2    Stubbs, J.B.3
  • 19
    • 0020396015 scopus 로고
    • Toxicity and response criteria of the Eastern Cooperative Oncology Group
    • COI: 1:STN:280:DyaL3s7kvFOgsw%3D%3D, PID: 7165009
    • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.
    • (1982) Am J Clin Oncol , vol.5 , pp. 649-655
    • Oken, M.M.1    Creech, R.H.2    Tormey, D.C.3    Horton, J.4    Davis, T.E.5    McFadden, E.T.6
  • 20
  • 21
    • 0032435802 scopus 로고    scopus 로고
    • Absolute organ activity estimated by five different methods of background correction
    • COI: 1:STN:280:DyaK1M%2FotlSmsA%3D%3D, PID: 9867163
    • Buijs WC, Siegel JA, Boerman OC, Corstens FH. Absolute organ activity estimated by five different methods of background correction. J Nucl Med. 1998;39:2167–72.
    • (1998) J Nucl Med , vol.39 , pp. 2167-2172
    • Buijs, W.C.1    Siegel, J.A.2    Boerman, O.C.3    Corstens, F.H.4
  • 22
    • 0024713937 scopus 로고
    • A Monte Carlo program for the simulation of scintillation camera characteristics
    • COI: 1:STN:280:DyaK3c%2FgsValtg%3D%3D, PID: 2791527
    • Ljungberg M, Strand SE. A Monte Carlo program for the simulation of scintillation camera characteristics. Comput Methods Programs Biomed. 1989;29:257–72.
    • (1989) Comput Methods Programs Biomed , vol.29 , pp. 257-272
    • Ljungberg, M.1    Strand, S.E.2
  • 23
    • 79957662849 scopus 로고    scopus 로고
    • Clinical dosimetry in the treatment of bone tumours: old and new agents
    • COI: 1:STN:280:DC%2BC3M3ltFChtQ%3D%3D, PID: 21386790
    • Hindorf C, Flux GD, Ibisch C, Bodéré Kraeber F. Clinical dosimetry in the treatment of bone tumours: old and new agents. Q J Nucl Med Mol Imaging. 2011;55:198–204.
    • (2011) Q J Nucl Med Mol Imaging , vol.55 , pp. 198-204
    • Hindorf, C.1    Flux, G.D.2    Ibisch, C.3    Bodéré Kraeber, F.4
  • 24
    • 0023901242 scopus 로고
    • Strontium-89 therapy: measurement of absorbed dose to skeletal metastases
    • COI: 1:STN:280:DyaL1c7ntFOjuw%3D%3D, PID: 3351609
    • Blake GM, Zivanovic MA, Blaquiere RM, Fine DR, McEwan AJ, Ackery DM. Strontium-89 therapy: measurement of absorbed dose to skeletal metastases. J Nucl Med. 1988;29:549–57.
    • (1988) J Nucl Med , vol.29 , pp. 549-557
    • Blake, G.M.1    Zivanovic, M.A.2    Blaquiere, R.M.3    Fine, D.R.4    McEwan, A.J.5    Ackery, D.M.6
  • 26
    • 23044470017 scopus 로고    scopus 로고
    • OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine
    • PID: 15937315
    • Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023–7.
    • (2005) J Nucl Med , vol.46 , pp. 1023-1027
    • Stabin, M.G.1    Sparks, R.B.2    Crowe, E.3
  • 27
    • 84897876213 scopus 로고    scopus 로고
    • Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP
    • COI: 1:CAS:528:DC%2BC3sXhsFKjt7fK, PID: 24077786
    • Pacilio M, Ventroni G, Basile C, Ialongo P, Becci D, Mango L. Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP. Eur J Nucl Med Mol Imaging. 2014;41:238–52.
    • (2014) Eur J Nucl Med Mol Imaging , vol.41 , pp. 238-252
    • Pacilio, M.1    Ventroni, G.2    Basile, C.3    Ialongo, P.4    Becci, D.5    Mango, L.6
  • 28
    • 34250354452 scopus 로고    scopus 로고
    • Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation
    • COI: 1:CAS:528:DC%2BD2sXmtl2jtLo%3D, PID: 17237963
    • Strigari L, Sciuto R, D’Andrea M, Pasqualoni R, Benassi M, Maini CL. Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation. Eur J Nucl Med Mol Imaging. 2007;34:1031–8.
    • (2007) Eur J Nucl Med Mol Imaging , vol.34 , pp. 1031-1038
    • Strigari, L.1    Sciuto, R.2    D’Andrea, M.3    Pasqualoni, R.4    Benassi, M.5    Maini, C.L.6
  • 29
    • 34447545672 scopus 로고    scopus 로고
    • A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases
    • COI: 1:CAS:528:DC%2BD2sXnsFOjt7k%3D, PID: 17625384
    • Liepe K, Kotzerke J. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases. Nucl Med Commun. 2007;28:623–30.
    • (2007) Nucl Med Commun , vol.28 , pp. 623-630
    • Liepe, K.1    Kotzerke, J.2
  • 30
    • 0026725284 scopus 로고
    • Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma
    • COI: 1:STN:280:DyaK38zgvFSlsw%3D%3D, PID: 1613572
    • Breen SL, Powe JE, Porter AT. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma. J Nucl Med. 1992;33:1316–23.
    • (1992) J Nucl Med , vol.33 , pp. 1316-1323
    • Breen, S.L.1    Powe, J.E.2    Porter, A.T.3
  • 31
    • 0032407291 scopus 로고    scopus 로고
    • Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP
    • PID: 9867152
    • van Rensburg AJ, Alberts AS, Louw WKA. Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP. J Nucl Med. 1998;39:2110–5.
    • (1998) J Nucl Med , vol.39 , pp. 2110-2115
    • van Rensburg, A.J.1    Alberts, A.S.2    Louw, W.K.A.3
  • 32
    • 0025358769 scopus 로고
    • Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer
    • PID: 1693784
    • Maxon HR, Schroder LE, Thomas SR, Hertzberg VS, Deutsch EA, Scher HI, et al. Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology. 1990;176:155–9.
    • (1990) Radiology , vol.176 , pp. 155-159
    • Maxon, H.R.1    Schroder, L.E.2    Thomas, S.R.3    Hertzberg, V.S.4    Deutsch, E.A.5    Scher, H.I.6
  • 33
    • 0025950294 scopus 로고
    • Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo
    • PID: 1717669
    • Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, et al. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. J Nucl Med. 1991;32:1877–81.
    • (1991) J Nucl Med , vol.32 , pp. 1877-1881
    • Maxon, H.R.1    Schroder, L.E.2    Hertzberg, V.S.3    Thomas, S.R.4    Englaro, E.E.5    Samaratunga, R.6
  • 34
    • 0037824534 scopus 로고    scopus 로고
    • Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases
    • COI: 1:CAS:528:DC%2BD3sXlt12js7w%3D, PID: 12791825
    • Liepe K, Hliscs R, Kropp J, Runge R, Knapp Jr FF, Franke WG. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. J Nucl Med. 2003;44:953–60.
    • (2003) J Nucl Med , vol.44 , pp. 953-960
    • Liepe, K.1    Hliscs, R.2    Kropp, J.3    Runge, R.4    Knapp, F.F.5    Franke, W.G.6
  • 35
    • 0022374032 scopus 로고
    • Strontium-89 therapy for the pain of osseous metastases
    • COI: 1:STN:280:DyaL2M7lvFymuw%3D%3D, PID: 3920361
    • Silberstein EB, Williams C. Strontium-89 therapy for the pain of osseous metastases. J Nucl Med. 1985;26:345–8.
    • (1985) J Nucl Med , vol.26 , pp. 345-348
    • Silberstein, E.B.1    Williams, C.2
  • 36
    • 0033923590 scopus 로고    scopus 로고
    • Systemic radiopharmaceutical therapy of painful osteoblastic metastases
    • COI: 1:STN:280:DC%2BD3cvovVSjsw%3D%3D, PID: 11034634
    • Silberstein EB. Systemic radiopharmaceutical therapy of painful osteoblastic metastases. Semin Radiat Oncol. 2000;10:240–9.
    • (2000) Semin Radiat Oncol , vol.10 , pp. 240-249
    • Silberstein, E.B.1
  • 37
    • 0034119348 scopus 로고    scopus 로고
    • Use of radionuclides for the palliation of bone metastases
    • COI: 1:STN:280:DC%2BD3c7psVSnsA%3D%3D, PID: 10727599
    • McEwan AJ. Use of radionuclides for the palliation of bone metastases. Semin Radiat Oncol. 2000;10:103–14.
    • (2000) Semin Radiat Oncol , vol.10 , pp. 103-114
    • McEwan, A.J.1
  • 38
    • 42149153360 scopus 로고    scopus 로고
    • Influence of human biokinetics of strontium on internal ingestion dose of 90Sr and absorbed dose of 89Sr to organs and metastases
    • COI: 1:CAS:528:DC%2BD1cXks1Glu70%3D, PID: 18204850
    • Li WB, Höllriegl V, Roth P, Oeh U. Influence of human biokinetics of strontium on internal ingestion dose of 90Sr and absorbed dose of 89Sr to organs and metastases. Radiat Environ Biophys. 2008;47:225–39.
    • (2008) Radiat Environ Biophys , vol.47 , pp. 225-239
    • Li, W.B.1    Höllriegl, V.2    Roth, P.3    Oeh, U.4
  • 39
    • 14844361408 scopus 로고    scopus 로고
    • Bone-seeking radionuclides for therapy
    • COI: 1:CAS:528:DC%2BD2MXhsVeksL0%3D, PID: 15653650
    • Lewington VJ. Bone-seeking radionuclides for therapy. J Nucl Med. 2005;46:38S–47S.
    • (2005) J Nucl Med , vol.46 , pp. 38-47
    • Lewington, V.J.1
  • 40
    • 84877358667 scopus 로고    scopus 로고
    • Monte Carlo simulation of age-dependent radiation dose from alpha- and beta-emitting radionuclides to critical trabecular bone and bone marrow targets
    • PID: 23615276
    • Dant JT, Richardson RB, Nie LH. Monte Carlo simulation of age-dependent radiation dose from alpha- and beta-emitting radionuclides to critical trabecular bone and bone marrow targets. Phys Med Biol. 2013;58:3301–19.
    • (2013) Phys Med Biol , vol.58 , pp. 3301-3319
    • Dant, J.T.1    Richardson, R.B.2    Nie, L.H.3
  • 41
    • 33746707858 scopus 로고    scopus 로고
    • High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
    • COI: 1:CAS:528:DC%2BD28XhtFWhsbfK, PID: 17062709
    • Bruland ØS, Nilsson S, Fisher DR, Larsen RH. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities? Clin Cancer Res. 2006;12:6250s–7s.
    • (2006) Clin Cancer Res , vol.12 , pp. 6250-6257
    • Bruland, Ø.S.1    Nilsson, S.2    Fisher, D.R.3    Larsen, R.H.4
  • 42
    • 79959437613 scopus 로고    scopus 로고
    • Alpha-particle microdosimetry
    • COI: 1:CAS:528:DC%2BC3MXhsVCqsLbL, PID: 22201713
    • Chouin N, Bardies M. Alpha-particle microdosimetry. Curr Radiopharm. 2011;4:266–80.
    • (2011) Curr Radiopharm , vol.4 , pp. 266-280
    • Chouin, N.1    Bardies, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.